The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
SaeGwang Park1,2,3, Zhujun Jiang1, Eric D. Mortenson2, Liufu Deng1, Olga Radkevich-Brown2, Xuanming Yang1, Husain Sattar2, Yang Wang1, Nicholas K. Brown2, Mark Greene4, Yang Liu5, Jie Tang1, Shengdian Wang1, Yang-Xin Fu1,2
1IBP-UC Group for Immunotherapy, CAS Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing 100101, China
2Department of Pathology and Committee on Immunology, University of Chicago, Chicago, IL 60637, USA
3Department of Microbiology, College of Medicine, University of INJE, 633-165, Gaegum-Dong, Jin-Gu, Busan, 614-735, Korea
4Department of Pathology, University of Pennsylvania, 252 John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104, USA
5Department of Surgery, University of Michigan, Ann Arbor, MI 48109 USA